HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 436 filers reported holding HORIZON THERAPEUTICS PUB L in Q3 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,746,006 | -85.5% | 153,685 | -87.1% | 0.01% | -85.7% |
| Q2 2023 | $122,786,766 | +31.8% | 1,193,495 | +45.9% | 0.04% | +5.0% |
| Q4 2022 | $93,135,947 | +69.2% | 818,274 | -4.8% | 0.04% | +66.7% |
| Q3 2022 | $55,044,000 | -23.8% | 859,802 | +1.5% | 0.02% | -29.4% |
| Q2 2022 | $72,281,000 | -29.2% | 847,078 | -12.2% | 0.03% | -30.6% |
| Q1 2022 | $102,134,000 | -26.2% | 965,253 | -24.1% | 0.05% | -32.9% |
| Q4 2021 | $138,313,000 | -4.5% | 1,271,492 | -2.3% | 0.07% | +10.6% |
| Q3 2021 | $144,758,000 | +86.5% | 1,301,543 | +60.2% | 0.07% | +69.2% |
| Q2 2021 | $77,624,000 | +740.8% | 812,468 | +700.9% | 0.04% | +550.0% |
| Q1 2021 | $9,232,000 | -73.4% | 101,450 | -77.0% | 0.01% | -73.9% |
| Q4 2020 | $34,759,000 | -17.1% | 441,701 | -15.6% | 0.02% | -34.3% |
| Q3 2020 | $41,912,000 | +16.0% | 523,244 | -16.0% | 0.04% | +6.1% |
| Q2 2020 | $36,138,000 | +5.6% | 623,059 | -42.0% | 0.03% | -15.4% |
| Q1 2020 | $34,218,000 | -13.2% | 1,074,384 | -1.4% | 0.04% | +30.0% |
| Q4 2019 | $39,444,000 | +8645.9% | 1,089,624 | +6460.8% | 0.03% | – |
| Q3 2019 | $451,000 | +390.2% | 16,608 | +333.5% | 0.00% | – |
| Q2 2019 | $92,000 | – | 3,831 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |